| Methods |
Type of trial: efficacy trial
Allocation: randomised
Intervention model: parallel assignment
Masking: single blinded (outcome assessors)
Primary purpose: treatment |
| Participants |
Condition: T2DM
Enrollment: estimated 80 participants
Inclusion criteria: T2DM
Exclusion criteria: hepatic or renal dysfunction, nutritional derangements, prior treatment with thiazolidinediones or metformin |
| Interventions |
Intervention(s): metformin
Comparator(s):
pioglitazone
sulphonylurea or insulin |
| Outcomes |
Primary outcome(s): serum pentosidine levels
Secondary outcome(s): —
Other outcome(s): — |
| Study details |
Trial identifier:JPRN-UMIN000002099 |
| Publication details |
Language of protocol: Japanese / English
Funding: —
Publication status: unpublished |
| Stated aim of study |
Quote: "The aim of the present study is to investigate the effects of metformin or pioglitazone on serum pentosidine levels" |
| Notes |
Only the protocol is available. Marked as a study awaiting classification due to a lack of data to assess inclusion. Trial authors have been contacted. |
